281 related articles for article (PubMed ID: 12820809)
1. Characterization of Pseudomonas aeruginosa isolates from patients with urinary tract infections during antibiotic therapy.
Horii T; Muramatsu H; Morita M; Maekawa M
Microb Drug Resist; 2003; 9(2):223-9. PubMed ID: 12820809
[TBL] [Abstract][Full Text] [Related]
2. Characterization of fluoroquinolone and carbapenem susceptibilities in clinical isolates of levofloxacin-resistant Pseudomonas aeruginosa.
Muramatsu H; Horii T; Takeshita A; Hashimoto H; Maekawa M
Chemotherapy; 2005 May; 51(2-3):70-5. PubMed ID: 15870499
[TBL] [Abstract][Full Text] [Related]
3. Carbapenem-resistant-only Pseudomonas aeruginosa infection in patients formerly infected by carbapenem-susceptible strains.
Tsai MH; Wu TL; Su LH; Lo WL; Chen CL; Liang YH; Chiu CH
Int J Antimicrob Agents; 2014 Dec; 44(6):541-5. PubMed ID: 25264129
[TBL] [Abstract][Full Text] [Related]
4. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
Lee JY; Ko KS
Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
[TBL] [Abstract][Full Text] [Related]
5. Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential.
Mushtaq S; Ge Y; Livermore DM
Antimicrob Agents Chemother; 2004 Aug; 48(8):3086-92. PubMed ID: 15273124
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
Akhi MT; Khalili Y; Ghotaslou R; Yousefi S; Kafil HS; Naghili B; Sheikhalizadeh V
Microb Drug Resist; 2018 Mar; 24(2):126-135. PubMed ID: 28654368
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons.
Rojo-Bezares B; Estepa V; Cebollada R; de Toro M; Somalo S; Seral C; Castillo FJ; Torres C; Sáenz Y
Int J Med Microbiol; 2014 May; 304(3-4):405-14. PubMed ID: 24594145
[TBL] [Abstract][Full Text] [Related]
8. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele.
Shu JC; Su LH; Chiu CH; Kuo AJ; Liu TP; Lee MH; Su IN; Wu TL
Microb Drug Resist; 2015 Apr; 21(2):149-57. PubMed ID: 25386722
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibilities and clinical characterization of Pseudomonas aeruginosa isolates from urinary tract infections.
Zhang X; Niu S; Zhang L
Urol Int; 2014; 93(4):464-9. PubMed ID: 24642393
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
Castanheira M; Deshpande LM; Costello A; Davies TA; Jones RN
J Antimicrob Chemother; 2014 Jul; 69(7):1804-14. PubMed ID: 24603963
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa.
Tam VH; Chang KT; LaRocco MT; Schilling AN; McCauley SK; Poole K; Garey KW
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):309-14. PubMed ID: 17617302
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Carbapenem Resistance in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from a Croatian Hospital.
Bubonja-Sonje M; Matovina M; Skrobonja I; Bedenic B; Abram M
Microb Drug Resist; 2015 Jun; 21(3):261-9. PubMed ID: 25565041
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
Mohanty S; Maurya V; Gaind R; Deb M
J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
[TBL] [Abstract][Full Text] [Related]
15. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.
Ocampo-Sosa AA; Cabot G; Rodríguez C; Roman E; Tubau F; Macia MD; Moya B; Zamorano L; Suárez C; Peña C; Domínguez MA; Moncalián G; Oliver A; Martínez-Martínez L;
Antimicrob Agents Chemother; 2012 Apr; 56(4):1703-13. PubMed ID: 22290967
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
[TBL] [Abstract][Full Text] [Related]
17. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
[TBL] [Abstract][Full Text] [Related]
18. Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA).
Shu JC; Chia JH; Siu LK; Kuo AJ; Huang SH; Su LH; Wu TL
Int J Antimicrob Agents; 2012 Mar; 39(3):217-22. PubMed ID: 22079532
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S
Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ
Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]